Tamara Turk WensveenUniversity of Rijeka1 paperOpenAlex ↗PapersFrontiers in EndocrinologyHuman trial·28 Sepγδ T-cell interferon-γ production reflects metabolic improvement during SGLT2 inhibitor-based therapy in type 2 diabetes
Frontiers in EndocrinologyHuman trial·28 Sepγδ T-cell interferon-γ production reflects metabolic improvement during SGLT2 inhibitor-based therapy in type 2 diabetes